Care China-Diabetes

NCT00938119 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1603

Last updated 2013-06-28

No results posted yet for this study

Summary

This multicenter, prospective, observational registry will assess efficacy and safety outcomes associated with percutaneous coronary intervention (PCI) with implantation of the CYPHER Select™+ Sirolimus-eluting Coronary Stents in Chinese diabetic patients with coronary artery disease in routine clinical practice.

Conditions

Sponsors & Collaborators

  • Johnson & Johnson Medical, China

    lead INDUSTRY

Principal Investigators

  • Yang Yue Jin, MD, Phd · Cardiovascular Institute & Fu Wai Hospital

  • Lv Shu Zheng, MD · Beijing Anzhen Hospital of the Capital University of Medical Sciences

  • Chen Yun Dai, MD, Phd · Chinese PLA General Hospital

  • Wang Le feng · Beijing Chaoyang Hospital Affiliated to the Capital University of Medical Sciences

  • Gao Wei, MD, Phd · Peking University Third Hospital

  • Wang Wei Min, MD, PhD · Peking University People's Hospital

  • Huo Yong, MD, PhD · Peking University First Hospital

  • Fang Quan, MD, PhD · Peking Union Medical College Hospital

  • He Qing, MD, PhD · Beijing Hospital

  • Liu Hui Liang, MD · General Hospital of Armed Police Forces

  • Li Hui, MD · General Hospital of Daqing Oilfield

  • Chen Ji Yan, MD, PhD · Guangdong Provincial People's Hospital

  • Du Zhi Min, MD · First Affiliated Hospital, Sun Yat-Sen University

  • Hou Yu Qing, MD · Southern Medical University, China

  • Li Wei Min, MD · First Affiliated Hospital of Harbin Medical University

  • Yu Bo, MD · The Second Affiliated Hospital of Harbin Medical University

  • Fu Guo Sheng, MD · Sir Run Run Shaw Hospital Affiliated with School of Medicine,Zhejiang University

  • Wang Jian An, MD, PhD · Second Affiliated Hospital, School of Medicine, Zhejiang University

  • Zhu Jian Hua, MD · First Affiliated Hospital of Zhejiang University College of Medicine

  • Liu Bin, MD · The Second Affiliated Hospital of Jilin University

  • Cui Lian Qun, MD, PhD · Shandong Provincial Hospital

  • Zhang Zheng, MD, PhD · Lanzhou University First Hospital

  • Chen Shao Liang, MD, PhD · The First Affiliated Hospital with Nanjing Medical University

  • Xu Biao, MD · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  • Li Lang, MD, PhD · First Affiliated Hospital of Guangxi Medical University

  • Ge Jun Bo, MD, PhD · Fudan University

  • He Ben, MD,PhD · Shanghai Jiaotong University School of Medicine affiliated Renji Hospital

  • Shen Wei Feng, MD, PhD · Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital

  • Xu Ya Wei, MD, PhD · Shanghai Tenth People's Hospital of Tongji University

  • Han Ya Ling, MD, PhD · General Hospital of Shenyang Military Region

  • Pang Wen Yue, MD, PhD · Shengjing Hospital

  • Li Bao, MD,PhD · Shanxi Cardiovascular Hospital

  • Lv Ji Yuan, MD · The First Affiliated Hospital of Shanxi Medical University

  • Liu Yin, MD, PhD · Tian Jin Chest Hospital

  • Qi Xiang Qian, MD · TEDA International Cardiovascular Hospital

  • Jiang Tie Min, MD · The Affiliated Hospital of Medical College of Chinese Armed Police Forces

  • Lu Cheng Zhi, MD · Tianjin First Central Hospital

  • Huang Wei Jian, MD, PhD · First Affiliated Hospital of Wenzhou Medical University

  • Sun Ying Xian, MD · First Hospital of China Medical University

  • Li Guo Qing, MD · People's Hospital of Xinjiang Uygur Autonomous Region

  • Yuan Zu Yi, MD · The First Hospital of Xian Jiao Tong University

  • Wang Hai Chang, MD · Xijing Hospital

  • Wang Yan, MD,PhD · Zhongshan Hospital Xiamen University

  • Gao Chuan Yu, MD, PhD · Henan Provincial People's Hospital

  • Wang Chun, MD, PhD · Peking University, Shen Zhen Hospital

  • Yong Wang, MD, PhD · China-Japan Friendship Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-11-30
Completion
2012-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00938119 on ClinicalTrials.gov